TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TRAX

First Tracks Biotherapeutics, Inc.

Healthcare · Biotechnology · —

35.80$ +0.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TRAX
Line item 2023 2024 2025
– -0.5% -25.2%
– -2.2% -18.9%
– +242.2% +93.5%
– -1.4% -19.1%
– +46.8% -14.4%
– +98.6% -14.3%
– +8.3% +8.1%
– +56.1% -17.8%
– -4.5% -26.6%
– +0.0% +0.0%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?